X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10140) 10140
Magazine Article (24) 24
Book Chapter (8) 8
Dissertation (4) 4
Newspaper Article (4) 4
Publication (3) 3
Newsletter (2) 2
Transcript (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9278) 9278
male (5532) 5532
female (5415) 5415
antineoplastic combined chemotherapy protocols - therapeutic use (4920) 4920
cytarabine - administration & dosage (4909) 4909
middle aged (4502) 4502
adult (4450) 4450
cytarabine - therapeutic use (3918) 3918
hematology (3171) 3171
oncology (3140) 3140
aged (3117) 3117
leukemia, myeloid, acute - drug therapy (2666) 2666
adolescent (2633) 2633
index medicus (2589) 2589
remission induction (1997) 1997
treatment outcome (1895) 1895
chemotherapy (1854) 1854
cytarabine (1699) 1699
child (1598) 1598
prognosis (1402) 1402
antineoplastic combined chemotherapy protocols - adverse effects (1332) 1332
cytarabine - adverse effects (1256) 1256
daunorubicin - administration & dosage (1212) 1212
cancer (1176) 1176
etoposide - administration & dosage (1176) 1176
antineoplastic agents - therapeutic use (1171) 1171
acute disease (1143) 1143
child, preschool (1078) 1078
combined modality therapy (1034) 1034
animals (1026) 1026
vincristine - administration & dosage (1018) 1018
cyclophosphamide - administration & dosage (1013) 1013
leukemia (1001) 1001
methotrexate - administration & dosage (986) 986
therapy (974) 974
acute myeloid leukemia (921) 921
acute myelogenous leukemia (899) 899
disease-free survival (880) 880
recurrence (848) 848
antineoplastic combined chemotherapy protocols - administration & dosage (825) 825
survival rate (800) 800
acute myeloid-leukemia (796) 796
leukemia, myeloid - drug therapy (775) 775
leukemia - drug therapy (759) 759
doxorubicin - administration & dosage (756) 756
survival analysis (748) 748
aged, 80 and over (739) 739
drug administration schedule (726) 726
daunorubicin - therapeutic use (701) 701
time factors (700) 700
leukemia, myeloid, acute - mortality (690) 690
infant (686) 686
retrospective studies (684) 684
drug therapy, combination (680) 680
follow-up studies (675) 675
vincristine - therapeutic use (674) 674
cyclophosphamide - therapeutic use (666) 666
young adult (653) 653
cytarabine - pharmacology (652) 652
transplantation (644) 644
mice (615) 615
prednisone - administration & dosage (614) 614
dose-response relationship, drug (607) 607
methotrexate - therapeutic use (583) 583
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (575) 575
leukemia, myeloid, acute - pathology (564) 564
bone marrow transplantation (548) 548
mitoxantrone - administration & dosage (547) 547
survival (544) 544
idarubicin - administration & dosage (523) 523
aml (522) 522
antimetabolites, antineoplastic - therapeutic use (521) 521
hematopoietic stem cell transplantation (519) 519
leukemia, myeloid, acute - genetics (481) 481
cytosine-arabinoside (465) 465
leukemia, myeloid, acute - therapy (461) 461
lymphoma, non-hodgkin - drug therapy (459) 459
pharmacology & pharmacy (458) 458
transplantation, autologous (453) 453
care and treatment (449) 449
prednisone - therapeutic use (446) 446
clinical trials as topic (436) 436
salvage therapy (435) 435
high-dose cytarabine (431) 431
dexamethasone - administration & dosage (427) 427
medicine & public health (425) 425
leukemia, lymphoid - drug therapy (417) 417
prospective studies (405) 405
children (402) 402
thioguanine - administration & dosage (394) 394
age factors (393) 393
risk factors (391) 391
bone marrow - pathology (383) 383
research (381) 381
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (380) 380
pediatrics (367) 367
stem cells (363) 363
mercaptopurine - administration & dosage (362) 362
antineoplastic agents - administration & dosage (356) 356
stem-cell transplantation (347) 347
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9084) 9084
Japanese (452) 452
German (211) 211
French (144) 144
Chinese (133) 133
Spanish (101) 101
Italian (68) 68
Russian (68) 68
Polish (65) 65
Czech (18) 18
Hungarian (13) 13
Dutch (9) 9
Portuguese (9) 9
Danish (8) 8
Hebrew (4) 4
Norwegian (4) 4
Serbian (3) 3
Slovak (3) 3
Swedish (3) 3
Croatian (2) 2
Romanian (2) 2
Bosnian (1) 1
Korean (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of clinical oncology, ISSN 1527-7755, 2017, Volume 35, Issue 20, pp. 2260 - 2267
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1691 - 1699
Summary Background Preclinical data and results from non-randomised trials suggest that the multikinase inhibitor sorafenib might be an effective drug for the... 
Hematology, Oncology and Palliative Medicine | AML | ONCOLOGY | ACUTE MYELOGENOUS LEUKEMIA | BONE-MARROW | CLASSIFICATION | FLT3 MUTATIONS | CYTARABINE | STEM-CELL TRANSPLANTATION | COMBINATION | ELDERLY-PATIENTS | CHEMOTHERAPY | Niacinamide - analogs & derivatives | Recurrence | Age Factors | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Protein Kinase Inhibitors - adverse effects | Transplantation, Homologous | Neoadjuvant Therapy - mortality | Time Factors | Phenylurea Compounds - adverse effects | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Chemotherapy, Adjuvant | Daunorubicin - therapeutic use | Double-Blind Method | Risk Factors | Kaplan-Meier Estimate | Niacinamide - adverse effects | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Treatment Outcome | Disease Progression | Leukemia, Myeloid, Acute - mortality | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Leukemia, Myeloid, Acute - diagnosis | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - adverse effects | Protein Kinase Inhibitors - therapeutic use | Germany | Antimitotic agents | Clinical trials | Chemotherapy | Antineoplastic agents | Standards | Cancer
Journal Article
Cancer, ISSN 0008-543X, 2015, Volume 121, Issue 23, pp. 4158 - 4164
BACKGROUND The long‐term efficacy of a combination of chemotherapy and dasatinib in patients with Philadelphia chromosome–positive (Ph+) acute lymphoblastic... 
dasatinib | acute lymphoblastic leukemia | chemotherapy | combination | Philadelphia chromosome | ADULT PATIENTS | ACUTE LYMPHOCYTIC-LEUKEMIA | REGIMEN | HYPER-CVAD | PONATINIB | THERAPY | ONCOLOGY | IMATINIB | MRD | Doxorubicin - therapeutic use | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Methotrexate - therapeutic use | Cyclophosphamide - therapeutic use | Neoplasm, Residual | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Aged, 80 and over | Vincristine - administration & dosage | Adult | Female | Philadelphia Chromosome | Doxorubicin - administration & dosage | Dexamethasone - administration & dosage | Dasatinib - therapeutic use | Treatment Outcome | Cytarabine - administration & dosage | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Dexamethasone - therapeutic use | Dasatinib - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Vincristine - therapeutic use | Methotrexate - administration & dosage | Aged | Dasatinib | Chemotherapy | Usage | Care and treatment | Lymphocytic leukemia | Stem cells | Dosage and administration | Transplantation | Diagnosis | Cancer
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 376, Issue 10, pp. 917 - 927
Journal Article
Blood, ISSN 1528-0020, 2016, Volume 127, Issue 1, pp. 71 - 78
Journal Article
Cancer, ISSN 0008-543X, 02/2016, Volume 122, Issue 4, pp. 559 - 564
BACKGROUND Double‐hit lymphomas (DHLs) are collectively defined as B‐cell non‐Hodgkin lymphomas harboring rearrangements of MYC as well as B‐cell lymphoma 2... 
BCL6 (B‐cell lymphoma 6) | non‐Hodgkin lymphoma | gene rearrangement | BCL2 (B‐cell lymphoma 2) | MYC | BCL6 (B-cell lymphoma 6) | non-Hodgkin lymphoma | BCL2 (B-cell lymphoma 2) | RITUXIMAB PLUS CYCLOPHOSPHAMIDE | TRANSLOCATIONS | IN-VIVO EFFICACY | DOXORUBICIN | B-CELL LYMPHOMA | PREDNISONE | BCL6 | ONCOLOGY | VINCRISTINE | EXPRESSION | Doxorubicin - therapeutic use | Prognosis | Cytarabine - therapeutic use | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Bone Marrow Neoplasms - genetics | Lymphoma, B-Cell - genetics | Cyclophosphamide - therapeutic use | Lymphoma, Non-Hodgkin - pathology | Burkitt Lymphoma - pathology | Burkitt Lymphoma - genetics | Female | Burkitt Lymphoma - drug therapy | Databases, Factual | Lymphoma, B-Cell - drug therapy | Lymphoma, Non-Hodgkin - drug therapy | Ifosfamide - therapeutic use | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Central Nervous System Neoplasms - genetics | Etoposide - therapeutic use | Survival Rate | Germinal Center - pathology | Lymphoma, Non-Hodgkin - genetics | DNA-Binding Proteins - genetics | Genes, bcl-2 - genetics | Rituximab - administration & dosage | Central Nervous System Neoplasms - pathology | Dexamethasone - therapeutic use | Bone Marrow Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gene Rearrangement | Genes, myc - genetics | Lymphoma, B-Cell - pathology | Vincristine - therapeutic use | Bone Marrow Neoplasms - drug therapy | Central Nervous System Neoplasms - drug therapy | Lymphoma, Large B-Cell, Diffuse - genetics | Prednisone - therapeutic use | Cohort Studies | Proto-Oncogene Proteins c-bcl-6 | Care and treatment | Chemotherapy | Usage | Non-Hodgkin's lymphomas | Diagnosis | Research | Oncogenes | Cancer
Journal Article
Haematologica, ISSN 0390-6078, 2017, Volume 102, Issue 2, pp. 356 - 363
Journal Article
Cancer science, ISSN 1347-9032, 2018, Volume 109, Issue 9, pp. 2830 - 2840